Results 31 to 40 of about 249,781 (322)

Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation: PRIME Study

Circulation, 2019
Background: The morbidity and mortality of patients with functional mitral regurgitation (MR) remain high, but no pharmacological therapy has been proven effective. The hypothesis of this study was that sacubitril/valsartan would be superior to valsartan
D. Kang, Sung-Ji Park, S. Shin, G. Hong, Sahmin Lee, Min-Seok Kim, S. Yun, Jong-Min Song, S. Park, Jae‐Joong Kim   +9 more
semanticscholar   +1 more source

Treatment of mitral regurgitation

Monaldi Archives for Chest Disease, 2017
<p class="Default">In the elderly mitral regurgitation is very frequent and surgical correction of mitral regurgitation (MR) has often a high operative risk, consequently, over the years, different percutaneous transcatheter techniques have been developed as a valid alternative to surgery.
Alberta Cifarelli, Diana Chin, Francesco De Felice, Roberto Violini   +3 more
openaire   +4 more sources

Midterm results of mitral valve repair for atrial functional mitral regurgitation: a retrospective study

Journal of Cardiothoracic Surgery, 2020
Background Annular dilation by left atrial remodeling is considered the main cause of atrial function mitral regurgitation. Although acceptable outcomes have been obtained using mitral ring annuloplasty alone for atrial functional mitral regurgitation ...
Daisuke Kaneyuki, Hiroyuki Nakajima, Toshihisa Asakura, Akihiro Yoshitake, Chiho Tokunaga, Masato Tochii, Jun Hayashi, Akitoshi Takazawa, Hiroaki Izumida, Atsushi Iguchi   +9 more
doaj   +1 more source

Adjunctive Techniques for Repair of Ischaemic Mitral Regurgitation

Cardiac Failure Review, 2021
Ischaemic mitral regurgitation is a complex process with debate in the literature as to the optimal treatment pathway. Multiple therapies are available to alleviate mitral regurgitation including medical management, transcatheter edge-to-edge repair ...
Sigrid L Johannesen, Colin M Barker, Melissa M Levack   +2 more
doaj   +1 more source

Experience of the management of coronary artery bypass graft only on moderate ischemic mitral regurgitation

Medicine, 2019
To summary the impact of off-pump coronary artery bypass grafting (CABG) only on patients with moderate ischemic mitral regurgitation and survival. We retrospectively analyzed 109 patients with coronary artery disease (CAD) complicated by moderate mitral
Weitie Wang, Bo Li, Yong Wang, Hulin Piao, Zhicheng Zhu, Rihao Xu, Dan Li, Kexiang Liu   +7 more
semanticscholar   +1 more source

Association of Mitral Valve Geometry at CT with Secondary Mitral Regurgitation after Transcatheter Aortic Valve Replacement in Patients with Aortic Regurgitation

Reviews in Cardiovascular Medicine
Background: The improvement rate and predictors of secondary mitral regurgitation in patients with aortic regurgitation undergoing transcatheter aortic valve replacement (TAVR) remain unclear.
Minyan Yin, Yuntao Lu, Xue Yang, Lili Dong, Xiaolin Wang, Lai Wei   +5 more
doaj   +1 more source

Quantitation of Mitral Regurgitation [PDF]

Circulation, 2012
Significant mitral regurgitation (MR) is estimated to afflict >2 million Americans and is anticipated to increase in prevalence as the baby boomer population ages.1 Approximately 10% of people ≥75 years of age have significant MR,1 and these patients have decreased survival regardless of whether MR is caused by a primary leaflet abnormality2 or is ...
Paul A. Grayburn, José Luis Zamorano, Neil J. Weissman   +2 more
openaire   +3 more sources

Two‐Stage Treatment for Adult Large Patent Ductus Venosus

Annals of Gastroenterological Surgery, EarlyView.
This is the first report of a two‐stage treatment for an adult large PDV involving the first stage surgical angioplasty of the large Arantius' duct and second stage embolization of the formed small Arantius' duct. The two‐stage approach could avoid embolic material migration into the systemic circulation or acute portal hypertension associated with the
Shohei Kudo, Shiro Onozawa, Ryosuke Miyauchi, Ryota Matsuki, Yoshihiro Sakamoto   +4 more
wiley   +1 more source

Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation.

New England Journal of Medicine, 2016
BACKGROUND In a randomized trial comparing mitral-valve repair with mitral-valve replacement in patients with severe ischemic mitral regurgitation, we found no significant difference in the left ventricular end-systolic volume index (LVESVI), survival ...
D. Goldstein, Alan J. Moskowitz, A. Gelijns, G. Ailawadi, M. Parides, L. Perrault, J. Hung, P. Voisine, F. Dagenais, A. Gillinov, V. Thourani, M. Argenziano, J. Gammie, M. Mack, P. Demers, P. Atluri, E. A. Rose, K. O’Sullivan, Deborah L. Williams, E. Bagiella, R. Michler, R. Weisel, Marissa A. Miller, N. Geller, W. Taddei-Peters, Peter K. Smith, E. Moquete, J. Overbey, I. Kron, P. O'Gara, M. Acker   +30 more
semanticscholar   +1 more source

The Behavioral Phenotype and Importance of Multidisciplinary Care in Patients With Sotos Syndrome: A Single‐Center Experience

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Sotos syndrome is an autosomal dominant condition caused by pathogenic variants in the NSD1 gene on chromosome 5q35. It is characterized by macrosomia, distinctive facial features, and developmental delays. Patients are also reported to have a behavioral phenotype including autism spectrum disorder, attention deficit/hyperactivity disorder ...
Aravind Viswanathan, Andrew M. George, Evan R. Hathaway, Carlyn Glatts, Jennifer M. Kalish   +4 more
wiley   +1 more source